18-minute watch
| Talk 2
of 6
Suggested for you
Explore suggested content tailored to your role within the CAR T-cell therapy journey
4-minute watch
ASH 2025: Expert Perspective
Visualizing Geographic Variation and Systemic Inequities of Disease Burden and CAR T-Cell Therapy Access in Multiple Myeloma in the US
Dr Brandon Blue
9-minute watch
EBMT 2026
Misconception: My patient isn
Dr Anna Sureda, Dr Birte Friedrichs, Dr Samuel Yamshon
15-minute watch
EBMT 2026
Misconception: The CAR T journey is too long for my patient to complete
Dr Samuel Yamshon
13-minute watch
EBMT 2026
Misconception: The CAR T journey is too long for my patient to complete
Dr Anna Sureda, Dr Birte Friedrichs, Dr Samuel Yamshon
22-minute watch
EBMT 2026
Misconception: The side effects of CAR T are too severe
Dr Birte Friedrichs
GFM-UNB-1778 November 2025
GFM-UNB-1778 November 2025
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. In the United Kingdom, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.
HCP Check with options
Select an option below that best describes your role to tailor the content you see: